Mariano Garcı́a-Yuste, MD, José M

Slides:

Advertisements

Similar presentations

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer Wu-Wei Lai, MD, Fen-Fen Chen, MD,

Advertisements

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Improved clinical outcomes in patients undergoing coronary artery bypass grafting with coronary endarterectomy Oz M Shapira, MD, Gabriel Akopian, Ali.

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Primary non-Hodgkin’s lymphoma of the lung

Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.

Chun Chieh Lin, PhD, MBA, Matthew P

Management of Carcinoid Tumors

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A

Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer Franz Blaes, MD, Markus Klotz, Hanno Huwer, MD, Uwe.

Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma Masahiro Yasunaga,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Morbidity and mortality after 94 extrapleural pneumonectomies for empyema Yuji Shiraishi, MD, Yutsuki Nakajima, MD, Akira Koyama, MD, Keiichiro Takasuna,

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Lung Cancer Surgery in Patients With Liver Cirrhosis

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors Akira Iyoda, MD, Kenzo Hiroshima, MD, Masayuki Baba,

Late outcomes of open heart surgery in patients 70 years or older

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic.

Prognostic factors in clinical stage I non–small cell lung cancer

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy Eduard L Mutsaerts, MSc, Frans A Zoetmulder, MD, Sybren Meijer,

Neuroendocrine tumors of the lung and octreotide scintigraphy

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Acute Kidney Injury Increases Mortality After Lung Transplantation

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer Wu-Wei Lai, MD, Fen-Fen Chen, MD,

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Adjustable Segmental Tricuspid Annuloplasty: Technical Advantages and Midterm Results Anas Sarraj, PhD, José-Manuel Nuche, PhD, Lourdes Domínguez, MD,

Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Henri Porte, MD, PhD, Joëlle Siat, MD, Benoit Guibert, MD, Francoise.

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Neal S Goldstein, MD The Annals of Thoracic Surgery

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer Bernward Passlick, MD, Boris Kubuschok, MD,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Joseph S Coselli, MD, Lori D Conklin, MD, Scott A LeMaire, MD

Adnan Cobanoglu, MD, Jess M Schultz, MD The Annals of Thoracic Surgery

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Coronary malperfusion due to type a aortic dissection: mechanism and surgical management Koji Kawahito, MD, Hideo Adachi, MD, Sei-ichiro Murata, MD,

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Presentation transcript:

Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study Mariano Garcı́a-Yuste, MD, José M. Matilla, MD, Tomás Alvarez-Gago, MD, José L. Duque, MD, Félix Heras, MD, Luis J. Cerezal, MD, Guillermo Ramos, MD The Annals of Thoracic Surgery Volume 70, Issue 1, Pages 258-263 (July 2000) DOI: 10.1016/S0003-4975(00)01369-2

Fig 1 Kaplan-Meier survival and log-rank test for patients with typical and atypical carcinoids. The Annals of Thoracic Surgery 2000 70, 258-263DOI: (10.1016/S0003-4975(00)01369-2)

Fig 2 Kaplan-Meier survival and log-rank test for patients with atypical carcinoids and grade 3 neuroendocrine carcinoma large cell type. The Annals of Thoracic Surgery 2000 70, 258-263DOI: (10.1016/S0003-4975(00)01369-2)

Fig 3 Kaplan-Meier survival and log-rank test for patients with grade 3 neuroendocrine carcinoma large and small cell type. The Annals of Thoracic Surgery 2000 70, 258-263DOI: (10.1016/S0003-4975(00)01369-2)